JPMorgan adds Tango Therapeutics to Analyst Focus List following Q3 earnings
JPLD JPMorgan Limited Duration Bond ETF
$51.33 -0.21%
View chart & analysis → - 1JPMorgan included Tango Therapeutics on its Analyst Focus List following the third-quarter earnings release.
- 2Analyst Brian Cheng maintained an overweight rating on Tango Therapeutics.
- 3JPMorgan raised its price target for Tango Therapeutics to $47 for December 2027.
So what's the key point?
JPMorgan selected Tango Therapeutics as a stock to watch. The firm expects the stock to rise further and increased its price target to $47.
Source Investing.com · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.